C12Y 207/04
Phosphotransferases with a phosphate group as acceptor
Official title: Phosphotransferases with a phosphate group as acceptor (2.7.4)
C12Y207/04 (Phosphotransferases with a phosphate group as acceptor) appears on 77 US grants and 176 published applications in this corpus.
Search patents in C12Y- Granted patents
- 77
- Published applications
- 176
- Assignees
- 110
- Inventors
- 456
- Latest grant
- 17 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1994 | 3 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 3 |
| 2003 | 0 | 5 |
| 2004 | 0 | 2 |
| 2005 | 0 | 3 |
| 2006 | 2 | 2 |
| 2007 | 1 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 2 |
| 2010 | 0 | 1 |
| 2011 | 0 | 2 |
| 2012 | 0 | 3 |
| 2013 | 1 | 1 |
| 2014 | 0 | 5 |
| 2015 | 2 | 6 |
| 2016 | 2 | 9 |
| 2017 | 1 | 9 |
| 2018 | 5 | 6 |
| 2019 | 3 | 16 |
| 2020 | 9 | 10 |
| 2021 | 6 | 14 |
| 2022 | 7 | 15 |
| 2023 | 12 | 14 |
| 2024 | 9 | 18 |
| 2025 | 10 | 18 |
| 2026 | 1 | 12 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12Y 207/04002Phosphomevalonate kinase23
- C12Y 207/04003Adenylate kinase16
- C12Y 207/04001Polyphosphate kinase15
- C12Y 207/04006Nucleoside-diphosphate kinase9
- C12Y 207/04014Ump/cmp kinase , i.e. uridine monophosphate kinase6
- C12Y 207/04008Guanylate kinase5
- C12Y 207/04026Isopentenyl phosphate kinase5
- C12Y 207/04009Dtmp kinase4
All 27 subgroupsShow fewer
- C12Y 207/04022Ump kinase3
- C12Y 207/04004Nucleoside-phosphate kinase2
- C12Y 207/04007Phosphomethylpyrimidine kinase1
- C12Y 207/0401Nucleoside-triphosphate--adenylate kinase1
- C12Y 207/04016Thiamine-phosphate kinase1
- C12Y 207/04011Adenylate kinase0
- C12Y 207/04012T-induced deoxynucleotide kinase0
- C12Y 207/04013Nucleoside-phosphate kinase0
- C12Y 207/04015Thiamine-diphosphate kinase0
- C12Y 207/040173-phosphoglyceroyl-phosphate--polyphosphate phosphotransferase0
- C12Y 207/04018Farnesyl-diphosphate kinase0
- C12Y 207/040195-methyldeoxycytidine-5'-phosphate kinase0
- C12Y 207/0402Dolichyl-diphosphate--polyphosphate phosphotransferase0
- C12Y 207/04021Inositol-hexakisphosphate kinase0
- C12Y 207/04023Ribose 1,5-bisphosphate phosphokinase0
- C12Y 207/04024Diphosphoinositol-pentakisphosphate kinase0
- C12Y 207/04025Cmp kinase0
- C12Y 207/04027[pyruvate, phosphate dikinase]-phosphate phosphotransferase0
- C12Y 207/04028[pyruvate, water dikinase]-phosphate phosphotransferase0
Recent patents
- Application of TPK as a target in Alzheimer's disease17 Mar 2026US 12,575,549 B2Shanghai Raising Pharmaceutical Co., Ltd.
- Engineered guanylate kinase variant enzymes18 Nov 2025US 12,473,557 B2Codexis, Inc.
- Bidirectional multi-enzymatic scaffolds for biosynthesizing cannabinoids12 Aug 2025US 12,385,072 B2Khona Scientific Holdings, Inc.
- Production method of enzymatic reaction using adenosine instead of ATP8 Jul 2025US 12,351,848 B2Anhui Gsh Bio-Tech Co., Ltd.
- Genetically encoded system for constructing and detecting biologically active agents13 May 2025US 12,297,234 B2The Regents of the University of Colorado, a body corporate
- Novel biosynthesis system for producing 3'-phosphoadenosine-5'-phosphosulfate and application thereof8 Oct 2026US 2026/0308651 A1Jiangnan University
- Methods and compositions for nucleic acid synthesis24 Sep 2026US 2026/0286415 A1Primrose Bio, Inc.
- Enzymatic conversion of d-xylose into d-ribose and d-ribulose-5-phosphate17 Sep 2026US 2026/0275395 A1Kookmin University Industry Academy Cooperation Foundation
- Methods and compositions for producing a carotenoid or terpenoid10 Sep 2026US 2026/0265710 A1
- Production of cannabinoids and engineered cells therefor23 Jul 2026US 2026/0209780 A1Cellibre, Inc.
Most cited
By later US patents
- Combined use of .beta.-galactosidase and sialyltransferase coupled with in situ regeneration of CMP-sialic acid for one pot synthesis of oligosaccharides130US 5,374,541 ACytel Corporation · 1994
- Method of inhibiting transformation of cells in which purine metabolic enzyme activity is elevated39US 5,324,731 AAmira, Inc. · 1994
- Isoprenoid production29US 6,989,257 B2Dsm IP Assets B.V. · 2006
- Methods of inhibiting undesirable cell growth using a combination of a cyclocreatine compound and a hyperplastic inhibitory agent24US 5,676,978 AAmira, Inc. · 1997
- Creatine analogs having antiviral activity22US 5,321,030 AAmira, Inc. · 1994